SLINGX CORP.
Update：2026/09/15
Industries
Main Industry
Health Care
Main Product/Service
1. "CardioRenix Matrix AI Smart Care Operating System": Creating the world's first clinical biochemical signal infrastructure layer integrating "decentralized real-time diagnosis, continuous AI risk prediction, and health insurance payment mechanisms," transforming medical records into digital smart assets.
2. "Matrix929™ Real-Time Microfluidic Analyzer": The exclusive patented N-DNA™ technology successfully overcomes the "Debye Screening Wall" that has blocked the industry for 30 years. With just a single drop of whole blood at your fingertip, you can generate central laboratory-level data within 15 minutes with sensitivity reaching fM (fimolar) levels, surpassing traditional optical inspection by 1,000 times. A single cartridge can quantitatively detect eight key CKM biomarkers including hs-cTnI, NT-proBNP, and HbA1c, quantifying micro-deterioration trends in organs.
3. "EvoRisk™ AI Prediction Engine and L1 Growth Memory Layer": This is the system's digital brain. The L1 growth memory layer uses MySQL (factual memory: biochemical indicators and prescriptions), Redis (state memory: real-time follow-up progress), and Graphiti (contextual memory: causal relationship maps of complaints and indicators) to transform static medical records into dynamic medical memory. The system self-optimizes through continuous learning mechanisms, predicting major cardiovascular adverse events (MACE) within 12 months with an accuracy of up to 0.90 AUC, advancing the intervention window by 5-10 years.
4. "Dr. AI Health Companion Assistant App": Integrates localized semantic mapping (TW-RAG), automatically de-hallucinating elderly Taiwanese slang names (such as "kidney guai"), and accurately maps them into SNOMED CT (code 709044004 chronic kidney disease) international standard clinical codes. When linked to Apple Watch, if acute warning signs such as HRV/HR anomalies are detected, the UI will be force-taken within 10 seconds to trigger an emergency alert status machine and immediately notify the medical team.
2. "Matrix929™ Real-Time Microfluidic Analyzer": The exclusive patented N-DNA™ technology successfully overcomes the "Debye Screening Wall" that has blocked the industry for 30 years. With just a single drop of whole blood at your fingertip, you can generate central laboratory-level data within 15 minutes with sensitivity reaching fM (fimolar) levels, surpassing traditional optical inspection by 1,000 times. A single cartridge can quantitatively detect eight key CKM biomarkers including hs-cTnI, NT-proBNP, and HbA1c, quantifying micro-deterioration trends in organs.
3. "EvoRisk™ AI Prediction Engine and L1 Growth Memory Layer": This is the system's digital brain. The L1 growth memory layer uses MySQL (factual memory: biochemical indicators and prescriptions), Redis (state memory: real-time follow-up progress), and Graphiti (contextual memory: causal relationship maps of complaints and indicators) to transform static medical records into dynamic medical memory. The system self-optimizes through continuous learning mechanisms, predicting major cardiovascular adverse events (MACE) within 12 months with an accuracy of up to 0.90 AUC, advancing the intervention window by 5-10 years.
4. "Dr. AI Health Companion Assistant App": Integrates localized semantic mapping (TW-RAG), automatically de-hallucinating elderly Taiwanese slang names (such as "kidney guai"), and accurately maps them into SNOMED CT (code 709044004 chronic kidney disease) international standard clinical codes. When linked to Apple Watch, if acute warning signs such as HRV/HR anomalies are detected, the UI will be force-taken within 10 seconds to trigger an emergency alert status machine and immediately notify the medical team.
Founded Year
2015
Unified Business No.
42625766
Status
Active
Number of Employees
7
Total Paid-in
Capital
1,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
SLINGX is a new medical technology startup team dedicated to new management of the "Cardiovascular-Kidney-Metabolic (CKM) syndrome." By providing real-time hemodynamic data monitoring systems, it connects critical gaps between heart and kidney health, and uses artificial intelligence to analyze clinical data to assist physicians in optimizing clinical judgments, enabling personalized treatment plans, It also effectively reduces readmission rates and the workload of medical staff.
